Last reviewed · How we verify

Avonex — Competitive Intelligence Brief

Avonex (Avonex) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Neuroscience.

marketed Interferon alpha/beta receptor Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Avonex (Avonex) — Biogen.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Avonex TARGET Avonex Biogen marketed Interferon alpha/beta receptor
Saphnelo ANIFROLUMAB AstraZeneca marketed Type I Interferon Receptor Antagonist [EPC] Interferon alpha/beta receptor 1 2021-01-01
Besremi ROPEGINTERFERON ALFA-2B Pharma Essentia Corporation marketed Interferon alfa-2b [EPC] Interferon alpha/beta receptor 2021-01-01
Plegridy PEGINTERFERON BETA-1A Biogen Idec Inc marketed Interferon beta [EPC] Interferon alpha/beta receptor 2014-01-01
Pegasys PEGINTERFERON ALFA-2A Hoffman-La Roche marketed Interferon alpha/beta receptor 2002-01-01
Avonex INTERFERON BETA-1A Biogen marketed Interferon beta [EPC] Interferon alpha/beta receptor 1996-01-01
Betaseron INTERFERON BETA-1B Bayer Healthcare Pharms marketed Interferon beta Interferon alpha/beta receptor 1993-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Avonex — Competitive Intelligence Brief. https://druglandscape.com/ci/avonex. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: